Systematic review of randomised controlled trials of sildenafil (Viagra) in the treatment of male erectile dysfunction.

BACKGROUND: Sildenafil (Viagra), a new oral drug for the treatment of erectile dysfunction, was licensed for use across Europe in 1998. AIM: To examine the effectiveness and safety of sildenafil as an oral treatment for erectile dysfunction. DESIGN OF STUDY: Systematic review and meta-analysis. SETT...

Full description

Bibliographic Details
Main Authors: Burls, A, Gold, L, Clark, W
Format: Journal article
Language:English
Published: 2001
_version_ 1826270799590326272
author Burls, A
Gold, L
Clark, W
author_facet Burls, A
Gold, L
Clark, W
author_sort Burls, A
collection OXFORD
description BACKGROUND: Sildenafil (Viagra), a new oral drug for the treatment of erectile dysfunction, was licensed for use across Europe in 1998. AIM: To examine the effectiveness and safety of sildenafil as an oral treatment for erectile dysfunction. DESIGN OF STUDY: Systematic review and meta-analysis. SETTING: All published or unpublished randomised controlled trials comparing sildenafil with a placebo or alternative therapies. METHOD: Published studies were sought by computerised searches of electronic databases using the keywords 'sildenafil' and 'Viagra'. A hand search was also done of the British Medical Journal, Lancet, Journal of the American Medical Association, New England Journal of Medicine, British journal of General Practice, Drug, Inpharma and Scrip. An assessment of quality of all identified studies and data extraction was undertaken independently by two researchers. Results were combined in a meta-analysis where appropriate, using RevMan version 3. RESULTS: Twenty-one trials were identified. All trials showed a statistically significant improvement in erectile or sexual function in patients using sildenafil compared with a placebo. A meta-analysis of 16 trials reporting a global efficacy response showed that men were 3.57 (95% CI = 2.93-4.43) times as likely to have improved erections on sildenafil compared with those on a placebo. The number needed to treat to have one man with improved erections was two. The drug has a relatively safe side-effect profile. CONCLUSIONS: Available research shows that sildenafil is an effective treatment for male erectile dysfunction. Many trial participants had some baseline erectile function and it is probable that in clinical practice, where the erectile function tends to be more impaired, the number needed to treat may be higher.
first_indexed 2024-03-06T21:46:29Z
format Journal article
id oxford-uuid:49c71b59-f019-4419-8008-3d8317981564
institution University of Oxford
language English
last_indexed 2024-03-06T21:46:29Z
publishDate 2001
record_format dspace
spelling oxford-uuid:49c71b59-f019-4419-8008-3d83179815642022-03-26T15:33:40ZSystematic review of randomised controlled trials of sildenafil (Viagra) in the treatment of male erectile dysfunction.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:49c71b59-f019-4419-8008-3d8317981564EnglishSymplectic Elements at Oxford2001Burls, AGold, LClark, WBACKGROUND: Sildenafil (Viagra), a new oral drug for the treatment of erectile dysfunction, was licensed for use across Europe in 1998. AIM: To examine the effectiveness and safety of sildenafil as an oral treatment for erectile dysfunction. DESIGN OF STUDY: Systematic review and meta-analysis. SETTING: All published or unpublished randomised controlled trials comparing sildenafil with a placebo or alternative therapies. METHOD: Published studies were sought by computerised searches of electronic databases using the keywords 'sildenafil' and 'Viagra'. A hand search was also done of the British Medical Journal, Lancet, Journal of the American Medical Association, New England Journal of Medicine, British journal of General Practice, Drug, Inpharma and Scrip. An assessment of quality of all identified studies and data extraction was undertaken independently by two researchers. Results were combined in a meta-analysis where appropriate, using RevMan version 3. RESULTS: Twenty-one trials were identified. All trials showed a statistically significant improvement in erectile or sexual function in patients using sildenafil compared with a placebo. A meta-analysis of 16 trials reporting a global efficacy response showed that men were 3.57 (95% CI = 2.93-4.43) times as likely to have improved erections on sildenafil compared with those on a placebo. The number needed to treat to have one man with improved erections was two. The drug has a relatively safe side-effect profile. CONCLUSIONS: Available research shows that sildenafil is an effective treatment for male erectile dysfunction. Many trial participants had some baseline erectile function and it is probable that in clinical practice, where the erectile function tends to be more impaired, the number needed to treat may be higher.
spellingShingle Burls, A
Gold, L
Clark, W
Systematic review of randomised controlled trials of sildenafil (Viagra) in the treatment of male erectile dysfunction.
title Systematic review of randomised controlled trials of sildenafil (Viagra) in the treatment of male erectile dysfunction.
title_full Systematic review of randomised controlled trials of sildenafil (Viagra) in the treatment of male erectile dysfunction.
title_fullStr Systematic review of randomised controlled trials of sildenafil (Viagra) in the treatment of male erectile dysfunction.
title_full_unstemmed Systematic review of randomised controlled trials of sildenafil (Viagra) in the treatment of male erectile dysfunction.
title_short Systematic review of randomised controlled trials of sildenafil (Viagra) in the treatment of male erectile dysfunction.
title_sort systematic review of randomised controlled trials of sildenafil viagra in the treatment of male erectile dysfunction
work_keys_str_mv AT burlsa systematicreviewofrandomisedcontrolledtrialsofsildenafilviagrainthetreatmentofmaleerectiledysfunction
AT goldl systematicreviewofrandomisedcontrolledtrialsofsildenafilviagrainthetreatmentofmaleerectiledysfunction
AT clarkw systematicreviewofrandomisedcontrolledtrialsofsildenafilviagrainthetreatmentofmaleerectiledysfunction